Stabilization of negative activation voltages of Cav1.3 L-Type Ca²⁺-channels by alternative splicing

References

• Striessnig J, Pinggera A, Kaur G, et al. L-type Ca2+ channels in heart and brain. Wiley Interdiscip Rev Membr Transp Signal. 2014;3(2):15–38.
   PubMedGoogle Scholar
• Zamponi GW, Striessnig J, Koschak A, et al. The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential. Pharmacol Rev. 2015;67:821–870.
   PubMed Web of Science ®Google Scholar
• Alexander SP, Striessnig J, Kelly E, et al. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: voltage-gated ion channels. Br J Pharmacol. 2017;174(Suppl 1):S160–s94.
   PubMedGoogle Scholar
• Koschak A, Reimer D, Huber I, et al. α1D (Cav1.3) Subunits Can Form L-type Ca2+ Channels Activating at Negative Voltages. J Biol Chem. 2001;276(25):22100–22106.
   PubMed Web of Science ®Google Scholar
• Mangoni ME, Couette B, Bourinet E, et al. Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity. Proc Natl Acad Sci U S A. 2003;100(9):5543–5548.
   PubMed Web of Science ®Google Scholar
• Marcantoni A, Baldelli P, Hernandez-Guijo JM, et al. L-type calcium channels in adrenal chromaffin cells: role in pace-making and secretion. Cell Calcium. 2007; 42(4-5):397–408.
   PubMed Web of Science ®Google Scholar
• Platzer J, Engel J, Schrott-Fischer A, et al. Congenital Deafness and Sinoatrial Node Dysfunction in Mice Lacking Class D L-Type Ca2+ Channels. Cell. 2000;102(1):89–97.
   PubMed Web of Science ®Google Scholar
• Brandt A, Striessnig J, Moser T. Ca V 1.3 Channels Are Essential for Development and Presynaptic Activity of Cochlear Inner Hair Cells. J Neurosci. 2003;23(34):10832–10840.
   PubMed Web of Science ®Google Scholar
• Olson PA, et al. G-Protein-Coupled Receptor Modulation of Striatal CaV1.3 L-Type Ca2+ Channels Is Dependent on a Shank-Binding Domain. J Neurosci. 2005;25(5):1050–1062.
   PubMed Web of Science ®Google Scholar
• Baig SM, Koschak A, Lieb A, et al. Loss of Cav1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness. Nat Neurosci. 2011;14(1):77–84..
   PubMed Web of Science ®Google Scholar
• Guzman JN, Sanchez-Padilla J, Chan CS, et al. Robust pacemaking in substantia nigra dopaminergic neurons. J Neurosci. 2009;29(35):11011–11019.
   PubMed Web of Science ®Google Scholar
• Liss B, Striessnig J. The Potential of L-Type Calcium Channels as a Drug Target for Neuroprotective Therapy in Parkinson’s Disease. Annu Rev Pharmacol Toxicol. 2019;59(1):263–289.
   PubMedGoogle Scholar
• Singh A, Gebhart M, Fritsch R, et al. Modulation of Voltage- and Ca2+ Gating of Ca V 1.3 L-type Calcium Channels by Alternative Splicing of a C-terminal Regulatory Domain. J Biol Chem. 2008;283(30):20733–20744.
   PubMed Web of Science ®Google Scholar
• Tan BZ, Jiang F, Tan MY, et al. Functional Characterization of Alternative Splicing in the C Terminus of L-type Cav1.3 Channels. J Biol Chem. 2011;286(49):42725–42735.
   PubMed Web of Science ®Google Scholar
• Bock G, Gebhart M, Scharinger A, et al. Functional Properties of a Newly Identified C-terminal Splice Variant of Cav1.3 L-type Ca 2+++ Channels. J Biol Chem. 2011;286(49):42736–42748.
   PubMed Web of Science ®Google Scholar
• Ortner NJ, Bock G, Dougalis A, et al. Lower Affinity of Isradipine for L-Type Ca2+ Channels during Substantia Nigra Dopamine Neuron-Like Activity: implications for Neuroprotection in Parkinson’s Disease. J Neurosci. 2017;37(28):6761–6777.
   PubMed Web of Science ®Google Scholar
• Scharinger A, Eckrich S, Vandael DH, et al. Cell-type-specific tuning of Cav1.3 Ca2+-channels by a C-terminal automodulatory domain. Tbr1. 2015;9:309.
   Google Scholar
• Pinggera A, Negro G, Tuluc P, et al. Gating defects of disease-causing de novo mutations in Cav1.3 Ca2+ channels. Channels (Austin). 2018;12(1):388–402.
   PubMed Web of Science ®Google Scholar
• Pinggera A, Striessnig SJ. Ca v 1.3 (CACNA1D) L-type Ca2+ channel dysfunction in CNS disorders. J Physiol. 2016;594(20):5839–5849.
   PubMed Web of Science ®Google Scholar
• Hofer NT, Tuluc P, Ortner NJ, et al. Biophysical classification of a CACNA1D de novo mutation as a high-risk mutation for a severe neurodevelopmental disorder. Mol Autism. 2020;11:4.
   PubMed Web of Science ®Google Scholar
• Xu W, Lipscombe D. Neuronal Cav1.3α 1 L-Type Channels Activate at Relatively Hyperpolarized Membrane Potentials and Are Incompletely Inhibited by Dihydropyridines. J Neurosci. 2001;21(16):5944–5951.
   PubMed Web of Science ®Google Scholar
• Liu N, Liu Y, Yang Y, et al. Linker flexibility of IVS3-S4 loops modulates voltage-dependent activation of L-type Ca2+ channels. Channel (Austin, Tex). 2017;11(1):34-45.
   Google Scholar
• Ortner NJ, Striessnig J. De novo CACNA1D Ca2+ channelopathies: clinical phenotypes and molecular mechanism. Pflüger`s Arch. 2020;472(7):755-773.
   Google Scholar
• Tumienė B, Maver A, Writzl K, et al. Diagnostic exome sequencing of syndromic epilepsy patients in clinical practice. Clin Genet. 2018;93(5):1057–1062.
   PubMed Web of Science ®Google Scholar
• Ortner NJ, Bock G, Vandael DHF, et al. Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators. Nat Commun. 2014;5(1):3897.
   PubMedGoogle Scholar
• Lieb A, Ortner N, Striessnig J. C-Terminal Modulatory Domain Controls Coupling of Voltage-Sensing to Pore Opening in Cav1.3 L-type Ca2+ Channels. Biophys J. 2014;106(7):1467–1475.
   PubMed Web of Science ®Google Scholar
• Paxinos G, Franklin KBJ. The Mouse Brain in Stereotaxic Coordinates. London: Elsevier Academic Press; 2004.
   Google Scholar
• Schlick B, Flucher BE, Obermair GJ. Voltage-activated calcium channel expression profiles in mouse brain and cultured hippocampal neurons. Neuroscience. 2010;167(3):786–798.
   PubMed Web of Science ®Google Scholar
• Pinggera A, Lieb A, Benedetti B, et al. CACNA1D de novo mutations in autism spectrum disorders activate Cav1.3 L-type calcium channels. Biol Psychiatry. 2015;77(9):816–822.
   PubMed Web of Science ®Google Scholar
• Pinggera A, Mackenroth L, Rump A, et al. New gain-of-function mutation shows CACNA1D as recurrently mutated gene in autism spectrum disorders and epilepsy. Hum Mol Genet. 2017;26(15):2923–2932.
   PubMed Web of Science ®Google Scholar
• Scholl UI, Goh G, Stolting G, et al. Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nature Genetics. 2013;45(9):1050–1054.
   PubMed Web of Science ®Google Scholar
• Flanagan SE, Vairo F, Johnson MB, et al. A CACNA1D mutation in a patient with persistent hyperinsulinaemic hypoglycaemia, heart defects, and severe hypotonia. Pediatr Diabetes. 2017;18(4):320–323.
   PubMed Web of Science ®Google Scholar
• Clark MB, Wrzesinski T, Garcia AB, et al. Long-read sequencing reveals the complex splicing profile of the psychiatric risk gene CACNA1C in human brain. Mol Psychiatry. 2020;25(1):37–47.
   PubMed Web of Science ®Google Scholar
• Huang H, Yu D, Soong TW. C-Terminal Alternative Splicing of Ca V 1.3 Channels Distinctively Modulates Their Dihydropyridine Sensitivity. Mol Pharmacol. 2013;84(4):643–653.
   PubMed Web of Science ®Google Scholar
• Coste de Bagneaux P, Campiglio M, Benedetti B, et al. Role of putative voltage-sensor countercharge D4 in regulating gating properties of Cav1.2 and Cav1.3 calcium channels. Channels (Austin). 2018;12(1):249–261.
   PubMed Web of Science ®Google Scholar
• Kaur G, Pinggera A, Ortner NJ, et al. A Polybasic Plasma Membrane Binding Motif in the I-II Linker Stabilizes Voltage-gated CaV1.2 Calcium Channel Function. J Biol Chem. 2015;290:21086–21100.
   PubMed Web of Science ®Google Scholar
• Wu J, Yan Z, Li Z, et al. Structure of the voltage-gated calcium channel Cav1.1 at 3.6 Å resolution. Nature. 2016;537(7619):191–196.
   PubMed Web of Science ®Google Scholar
• LaCarubba B, Bunda A, Savage K, et al. Developmental and cell-specific expression of Cacna1d splice variants. bioRxiv. 2019. doi:https://doi.org/10.1101/598722.
   Google Scholar
• Li G, Wang J, Liao P, et al. Exclusion of alternative exon 33 of Cav1.2 calcium channels in heart is proarrhythmogenic. Proc Natl Acad Sci U S A. 2017;114(21):E4288–E95.
   PubMed Web of Science ®Google Scholar
• Van den Maagdenberg AMJM, Pizzorusso T, Kaja S, et al. High cortical spreading depression susceptibility and migraine-associated symptoms in Cav2.1 S218L mice. Ann Neurol. 2010;67(1):85-98.
   Google Scholar
• Pietrobon D. CaV2.1 channelopathies. Pflugers Arch. 2010;460(2):375–393.
   PubMedGoogle Scholar
• Pietrobon D, Striessnig J. Neurobiology of migraine. Nat Rev Neurosci. 2003;4:386–398.
   PubMed Web of Science ®Google Scholar
• Ortner NJ, Pinggera A, Hofer NT, et al. RBP2 stabilizes slow Cav1.3 Ca2+ channel inactivation properties of cochlear inner hair cells. Pflugers Arch. 2020;472:3-25.
   Google Scholar
• Williams ME, Feldman DH, McCue AF, et al. Structure and functional expression of alpha 1, alpha 2, and beta subunits of a novel human neuronal calcium channel subtype. Neuron. 1992;8(1):71-84.
   PubMed Web of Science ®Google Scholar
• Ihara Y, Yamada Y, Fujii Y, et al. Molecular diversity and functional characterization of voltage- dependent calcium channels (CACN4) expressed in pancreatic beta-cells. Mol Endocrinol. 1995;9:121–130.
   PubMedGoogle Scholar
• Perez-Reyes E, Castellano A, Kim HS, et al. Cloning and expression of a cardiac/brain beta subunit of the L-type calcium channel. J Biol Chem. 1992;267:1792–1797.
   PubMed Web of Science ®Google Scholar
• Seino S, Chen L, Seino M, et al. Cloning of the alpha 1 subunit of a voltage-dependent calcium channel expressed in pancreatic beta cells.. Proc Natl Acad Sci U S A. 1992;89(2):584–588.
   PubMed Web of Science ®Google Scholar
• Liaqat K, Schrauwen I, Raza SI, et al. Identification of CACNA1D variants associated with sinoatrial node dysfunction and deafness in additional Pakistani families reveals a clinical significance. Journal of Human –Genetics. 2019;64(2):153–160.
   PubMed Web of Science ®Google Scholar
• Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–423.
   Web of Science ®Google Scholar
• Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7):research0034.1.
   PubMed Web of Science ®Google Scholar